Zobrazeno 1 - 10
of 256
pro vyhledávání: '"AKIRA HAMADA"'
Autor:
Shuta Ohara, Kenichi Suda, Akira Hamada, Masato Chiba, Masaoki Ito, Masaki Shimoji, Toshiki Takemoto, Junichi Soh, Yasuhiro Tsutani
Publikováno v:
Thoracic Cancer, Vol 15, Iss 31, Pp 2229-2234 (2024)
Abstract Background Superior outcomes have been obtained for neoadjuvant treatment with immune checkpoint inhibitors (ICI) plus chemotherapy over neoadjuvant chemotherapy alone, especially in patients with high programmed cell death ligand 1 (PD‐L1
Externí odkaz:
https://doaj.org/article/01fa212b64f949ff8f69a1fbe25e8ccd
Autor:
Shota Fukuda, Kenichi Suda, Akira Hamada, Hana Oiki, Shuta Ohara, Masaoki Ito, Junichi Soh, Tetsuya Mitsudomi, Yasuhiro Tsutani
Publikováno v:
Biomedicines, Vol 12, Iss 7, p 1412 (2024)
The emergence of acquired resistance to EGFR-tyrosine kinase inhibitors (TKIs) is almost inevitable even after a remarkable clinical response. Secondary mutations such as T790M and C797S are responsible for the resistance to 1st/2nd-generation (1/2G)
Externí odkaz:
https://doaj.org/article/13cb6c41316240a794f6123d8ca258da
Autor:
Akira Hamada, MD, PhD, Kazuhiro Kitajima, MD, PhD, Kenichi Suda, MD, PhD, Takamasa Koga, MD, PhD, Junichi Soh, MD, PhD, Hayato Kaida, MD, PhD, Kimiteru Ito, MD, PhD, Tetsuro Sekine, MD, PhD, Kyoshiro Takegahara, MD, PhD, Hiromitsu Daisaki, PhD, Masaki Hashimoto, MD, PhD, Yukihiro Yoshida, MD, PhD, Takanobu Kabasawa, MD, PhD, Takashi Yamasaki, MD, Seiichi Hirota, MD, PhD, Jitsuo Usuda, MD, PhD, Kazunari Ishii, MD, PhD, Tetsuya Mitsudomi, MD, PhD
Publikováno v:
JTCVS Open, Vol 14, Iss , Pp 502-522 (2023)
Objectives: Despite the prognostic impacts of preoperative fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography examination, fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography–based prognosis
Externí odkaz:
https://doaj.org/article/e19c0aed51314bcc89b498ce4c184a36
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
For decades, lobectomy has been the recommended surgical procedure for non-small cell lung cancer (NSCLC), including for small-sized lesions. However, two recent pivotal clinical trials conducted by the Japanese Clinical Oncology Group/West Japan Onc
Externí odkaz:
https://doaj.org/article/417750a70eea475999ca3c1f3e1964ff
Autor:
Takamasa Koga, MD, PhD, Junichi Soh, MD, PhD, Akira Hamada, MD, PhD, Yuki Miyano, MS, Toshio Fujino, MD, PhD, Keiko Obata, Shuta Ohara, MD, PhD, Masaya Nishino, MD, PhD, Masato Chiba, MD, PhD, Masaki Shimoji, MD, PhD, Toshiki Takemoto, MD, PhD, Kenichi Suda, MD, PhD, Kazuko Sakai, MD, PhD, Hidenori Sato, PhD, Tetsuya Mitsudomi, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 9, Pp 100554- (2023)
Introduction: Lung tumor organoids (LTOs) have attracted attention as in vitro preclinical models; however, their clinical and experimental applications have not been fully established. Methods: We attempted to establish LTOs from resected specimens
Externí odkaz:
https://doaj.org/article/e9026793576d4c6aace4c65a0c8269ab
Autor:
Toshio Fujino, Kenichi Suda, Takamasa Koga, Akira Hamada, Shuta Ohara, Masato Chiba, Masaki Shimoji, Toshiki Takemoto, Junichi Soh, Tetsuya Mitsudomi
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-14 (2022)
Abstract Background Capmatinib and tepotinib are guideline-recommended front-line treatments for non-small-cell lung cancer (NSCLC) patients with MET exon 14 skipping mutations (METex14). However, the emergence of acquired resistance to capmatinib/te
Externí odkaz:
https://doaj.org/article/91f7932bd36f4d28ab9a6bce380f3ecc
Publikováno v:
Biomolecules, Vol 13, Iss 9, p 1377 (2023)
Several clinical trials have been revolutionizing the perioperative treatment of early-stage non-small cell lung cancer (NSCLC). Many of these clinical trials involve cancer immunotherapies with antibody drugs that block the inhibitory immune checkpo
Externí odkaz:
https://doaj.org/article/0444c87989cc455ea42db0fd78dfab72
Autor:
Akira Hamada, Shuichi Takaki
Publikováno v:
Frontiers in Psychology, Vol 13 (2022)
Assessing learners’ individual differences helps identify students who need teacher support in classrooms. Previous studies have examined second language (L2) achievement based on reading anxiety because reading is an input-based activity essential
Externí odkaz:
https://doaj.org/article/7b06e3804c7141a68b413ec20acc790f
Autor:
Akira Hamada, MD, Kenichi Suda, MD, PhD, Toshio Fujino, MD, PhD, Masaya Nishino, MD, PhD, Shuta Ohara, MD, PhD, Takamasa Koga, MD, PhD, Takanobu Kabasawa, MD, PhD, Masato Chiba, MD, PhD, Masaki Shimoji, MD, PhD, Makoto Endoh, MD, PhD, Toshiki Takemoto, MD, PhD, Junichi Soh, MD, PhD, Naoki Yanagawa, MD, PhD, Satoshi Shiono, MD, PhD, Tetsuya Mitsudomi, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 5, Pp 100321- (2022)
Introduction: Recent studies have suggested that including presence or absence of ground-glass opacity (GGO) may improve the tumor descriptor (T descriptor) classification in clinical stage I NSCLC. In this study, we analyzed prognostic implications
Externí odkaz:
https://doaj.org/article/e3038b81b06d4260b05a610326300a03
Autor:
Shuta Ohara, Kenji Tomizawa, Shigeki Shimizu, Kenichi Suda, Toshio Fujino, Akira Hamada, Takamasa Koga, Masaya Nishino, Yoshihisa Kobayashi, Katsuaki Sato, Masato Chiba, Masaki Shimoji, Toshiki Takemoto, Junichi Soh, Tetsuya Mitsudomi
Publikováno v:
Surgical Case Reports, Vol 5, Iss 1, Pp 1-4 (2019)
Abstract Background A total of 75% of patients with Sjögren’s syndrome are complicated with pulmonary lesions, of which 12% are lymphoma and 6% are amyloid nodules; the coexistence of both is considered to be rare. Case presentation A 67-year-old
Externí odkaz:
https://doaj.org/article/5a843bab51b7499ab8dcdf89c1b00bd6